Intrinsic Value of S&P & Nasdaq Contact Us

EssilorLuxottica S.A. ESLOY OTC

Other OTC • Healthcare • Medical - Instruments & Supplies • FR • USD

SharesGrow Score
53/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

EssilorLuxottica S.A. (ESLOY) reported total assets of $63.87B and total liabilities of $24.39B for fiscal year 2025, resulting in total equity of $39.48B.

The company held $3.54B in cash and short-term investments. Total debt stood at $17.04B, with net debt of $13.5B. The Debt-to-Equity (D/E) ratio was 0.43 (conservative).

Current ratio is 0.99, which may signal tight short-term liquidity. Interest coverage is 14.1x (strong).

Criteria supported by this page:

  • HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
  • MOAT (81/100) — Total assets $63.87B and equity $39.48B support the company's competitive scale
  • VALUE (15/100) — Debt-to-Equity 0.43 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 53/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
53/100
SG Score
View full scorecard →
VALUE
15/100
Price-to-Earnings & upside
→ Valuation
FUTURE
20/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
81/100
→ Income
~
GROWTH
45/100
→ Income
~
INCOME
45/100
→ Income
EssilorLuxottica S.A. Balance Sheet History
Metric FY2025 FY2024 FY2023 FY2022
Total Assets $63.87B$64.26B$60.52B$60.56B
Total Liabilities $24.39B$23.26B$21.63B$22.41B
Total Debt $17.04B$13.22B$11.66B$12.2B
Cash & Investments $3.54B$2.25B$2.56B$1.99B
Total Stockholders Equity $38.87B$40.38B$38.24B$37.46B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message